Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Kedrion Biopharma is an international biopharmaceutical company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products. These products are used to treat and prevent a variety of serious conditions, such as hemophilia, immune deficiencies, and other rare diseases. With a strong global presence, Kedrion is committed to innovation, quality, and ensuring access to life-saving therapies for patients worldwide. The company has a rich heritage in the field and continues to expand its operations and research efforts to meet growing healthcare needs.
Serves as the global corporate headquarters, overseeing strategic direction, research and development initiatives, core administrative functions, and international operations.
The headquarters are situated in a region known for its natural beauty and historical significance, reflecting a blend of modern biopharmaceutical operations within a traditional Italian setting. Facilities likely include advanced administrative offices and potentially research labs.
The work culture at Kedrion's HQ likely emphasizes scientific excellence, collaboration, a strong sense of responsibility towards patients, and a commitment to quality, influenced by its Italian heritage and global operational standards.
The Lucca headquarters is pivotal as the birthplace and central nervous system of Kedrion's global network, driving its mission to provide plasma-derived therapies worldwide. It symbolizes the company's roots and its growth into a major international player.
Kedrion Biopharma supports a wide range of functions globally, including research and development, plasma collection through its network of KEDPLASMA centers primarily in the US and Europe, advanced manufacturing of plasma-derived therapies in Italy, Hungary, and the US, and commercial operations and distribution networks spanning over 100 countries. This integrated global footprint allows Kedrion to manage the entire plasma lifecycle, from donor to patient, ensuring a reliable supply of life-saving medicines worldwide.
Loc. Ai Conti
Castelvecchio Pascoli, Barga
Lucca (LU), Tuscany
Italy
Address: 400 Kelby Street, Fort Lee, NJ 07024, USA
Strategic hub for managing and expanding Kedrion's presence in the significant North American plasma-derived therapies market.
Address: 1815 Walt Whitman Rd, Melville, NY 11747, USA
Integral part of Kedrion's US manufacturing and supply chain for plasma-derived therapies.
Address: Human BioPlazma Kft., Táncsics Mihály út 91, Gödöllő, 2100, Hungary
Enhances Kedrion's manufacturing capacity and supply chain resilience within Europe, serving both regional and international markets.
Address: Via Provinciale, Frazione Bolognana, Gallicano, Lucca, Italy
A cornerstone of Kedrion's Italian and global manufacturing network, contributing significantly to its product portfolio.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Kedrion Biopharma' leadership includes:
Kedrion Biopharma has been backed by several prominent investors over the years, including:
The most significant recent executive change was the appointment of Val Romberg as CEO following the acquisition by Permira and combination with BPL. Other adjustments may have occurred as part of the integration and strategic alignment.
Discover the tools Kedrion Biopharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Kedrion Biopharma commonly uses the email format of first initial followed by last name. Other formats might exist but this is a frequently observed pattern.
[first_initial][last]@[kedrion.com]
Format
jdoe@kedrion.com
Example
80%
Success rate
Permira • January 24, 2023
Permira announced the completion of the acquisition of Kedrion and Bio Products Laboratory (BPL), and their combination to create a global leader in plasma-derived medicines. Val Romberg was appointed as CEO of the newly combined group....more
Kedrion Biopharma • September 1, 2022
The Permira Funds announced that they have completed the joint acquisition and combination of Kedrion and BPL. The Marcucci family and FSI retain a significant minority stake in Kedrion....more
Kedrion Biopharma • May 8, 2024
Kedrion Biopharma announced that the U.S. Food and Drug Administration (FDA) has approved IGNext® [Immune Globulin Intravenous (Human), 10% Liquid] for the treatment of primary immunodeficiency. This marks a significant milestone in expanding their portfolio of life-saving therapies....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Kedrion Biopharma, are just a search away.